Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96

Keikawus Arastéh, Patrick Yeni, Anton Pozniak, Beatriz Grinsztejn, Dushyantha Jayaweera, Afsoon Roberts, Jennifer Hoy, Sandra De Meyer, Tony Vangeneugden, Frank Tomaka

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96'. Together they form a unique fingerprint.

Medicine & Life Sciences